
The Louis Family laboratory for targeted drug delivery & personalized medicine technologies
ABOUT US
In our research group, we aim to improve patients' quality of life and treatment by developing innovative medical technologies. Specifically, we focus on targeted drug delivery systems to treat brain neurodegenerative diseases. Our nanotechnology is designed according to the loaded drug (proteins, gene delivery, and small molecules) and to the brain-targeting region. We also utilize our technology to treat various metastatic cancer types and inflammations and combine it with synthetic biology to develop artificial cells for therapeutic applications. Our lab is headed by Prof. Avi Schroeder, who has years of experience in nanotechnology and personalized medicine technologies. Avi Schroeder is a tenured Professor of Chemical Engineering at the Technion Israel Institute of Technology, where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies.
Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology (MIT) with Robert Langer and Daniel G. Anderson, and his PhD jointly at the Hebrew and Ben Gurion Universities with Chezy Barenholz and Joseph Kost. Avi is the recipient of more than 30 national and international awards, including being named a KAVLI Fellow, the Intel Nanotechnology, TEVA Pharmaceuticals, and the Wolf Foundation Krill Awards. Avi is the author of more than 80 papers, the inventor of over 20 patents, and the co-founder of multiple startup companies based on these discoveries.
Schroeder is a former member of the Israel Young National Academy of Sciences, and a current member of Israel’s National Council for Civilian Research and Development, and the President-elect of the Controlled Release Society (CRS).
Our research is supported by:




H2020-ERC grant
ERC-STG-2015-680242
Horizon Europe
ERC-COG-2022-101089009
ERC POC-2022-101113408
European Innovation Council
PERSEUS
Israel Science Foundation
346
Years of Experience
1
Billion Liposomes
58
Countries Visited
24
Staff Children
OUR TEAM

Avi received all three degrees in Chemical Engineering from the Ben-Gurion University. His postdoctoral training at the Massachusetts Institute of Technology (2012). At MIT, Avi and colleagues developed nanoparticles that are capable of autonomously synthesizing proteins upon signal, thereby being a platform for on-site delivery of drugs and preventing damage to healthy organs. In our lab, Avi is building an expert team to work towards improved personalized and targeted medicine.

Having received her Bachelor's, Master's, and Ph.D. from the Technion, Jeny specialized in embryonic CNS cell removal under the guidance of Dr. Estee Kurant's guidance. Post-PhD, she joined Griffith’s Lab at UC Davis, contributing to endothelial cell recellularization and developing methods for antigen removal. Since 2019, Jeny serves as a lab manager and senior scientist in Schroeder lab, driving research, managing grants and fostering industry collaborations.

Joined the Schroeder group as Lab Engineer in 2022.

Egor received his integrated MSc degree in Medical Biochemistry at The University of Manchester (2019) having completed his project in Taylor's lab in MCRC. Egor joined the lab in 2020 and is currently studying towards his PhD in Nanotechnology. Egor's work is centred in the engineering of a revolutionary lipid nanoparticle for RNA delivery using robotics. Moreover, Egor developped an academic course that teaches nanotechnology using remote experimentation.

Shaked completed her BSc in Biochemical Engineering at the Technion (2017). Initially joined the lab as an undergraduate student, and is now a Ph.D. candidate. Shaked is focusing her studies on improving the brain's uptake of LNP (Lipid Nanoparticles) for treating neurodegenerative diseases.

Shanny received her B.Sc. in Biotechnology and Food Engineering from the Technion (2021). In 2020, she joined the Schroeder lab's synthetic cells group and is presently working towards her Ph.D., researching methods to prolong the activity of synthetic cells through the enhancement of their energy pathways.

Noga received her B.Sc in Biochemical Engineering at the Technion (2016). Noga has been working for 3 years as R&D engineer in NanoSpun Technologies and has joined the team in February 2019. In her current M.Sc research, Noga is focusing on designing synthetic cells system as a base for therapeutic applications.

Yuval received her B.Sc. in Biotechnology and Food Engineering at the Technion in 2024. She joined the brain delivery team the same year as an undergraduate research student and is currently pursuing her M.Sc., focusing on treatments for neurodegenerative diseases.

Dana earned her MD degree from Tel Aviv University (2010) and completed her Paediatrics Residency at Sheva Medical Centre (2015). She was named an Outstanding Fellow during her Pediatric Hemato-Oncology fellowship at Schneider Children's Medical Center (2018). Since 2020, she has served as a Senior Pediatric Oncologist at Rambam Medical Center. Dana's PhD focuses on the mechanism of bone healing in LCH lesions and the Perseus project.

Yael received her B.Sc. in Chemical Engineering at the Technion in 2024 and joined the Synthetic Cell team in 2025 as a M.Sc. student. Her research focuses on nanoparticles-meditated delivery to synthetic cells.

Omer received his B.Sc. in Biochemical Engineering from the Technion in 2024. During his undergraduate studies, he joined the Synthetic Cells team, focusing on automation in synthetic cell production. In 2024, Omer began his M.Sc., aiming to incorporate kinetic modelling and computational tools with synthetic cells for various applications.

Mia received her B.Sc. in Biochemical engineering from the Technion on 2021. Mia joined the team in 2019 as an undergraduate student, and in her current Ph.D. research she is developing a platform for delivering large DNA payload to the brain.

Igal received his B.Sc. in Biochemical Engineering from the Technion in 2024. Initially, Igal joined the team in 2021 as an undergraduate student, and in his current M.Sc. research he is developing of a platform for the delivery of mRNA payload in plants.

Yasmin received her B.Sc in Biomedical Engineering at the Technion (2024) and joined the lab that same year as a M.Sc student. She is entering the field of synthetic cells, aiming to incorporate “sense and respond” mechanisms into the system.

Haim received his B.Sc. in Biochemical engineering from the Technion in 2024. Haim joined the team in 2021 as an undergraduate student, and in his current M.Sc research he is developing a platform for targeted delivery of nanoparticles to the brain.

Joined the Schroeder group as Administrative Assistant in 2022.

Reaam received her B.Sc. in Biochemical Engineering at the Technion in 2024 and joined the brain delivery team the same year as a M.Sc. student. Her research focuses on developing nanoparticles for neurotransmission restoration in neurodegenerative diseases.

Janna received her B.Sc. in Biotechnology and Food Engineering from the Technion- Israel Institute of Technology (2007). She completed her Ph.D. Studies under the supervision of Prof. Ayelet Fishman in the same department. Her research focused on production of valuable chiral sulfoxides using oxidizing enzymes. Janna joined Dr. Schroeder group and served as a lab director and senior scientist, involved in many projects in the lab.






OUR LAB
CONTACT US
Our Address
Department of Chemical Engineering,
Technion – Israel Institute of Technology
Rooms: 351 (office); 101-102 (lab)
Haifa 32000, ISRAEL
Prof. Avi Schroeder: avids@technion.ac.il
Tel (Avi): +972-73-378-1953 // (lab) +972-73-378-1862





























